The Emergency Care Access & Timeliness eCQM was submitted to the CBE for endorsement review in the Fall 2024 cycle (CBE #4625e), and the CBE endorsed the measure for use in the REHQR Program with conditions on February 12, 2025
Whether you're just starting your wellness journey or ready to take things to the next level, our team is here to help you feel amazing from the inside out.
Tirzepatide is a novel medication approved by the FDA for the treatment of type 2 diabetes (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)
This observation suggests that GLP-1 receptor agonists may be used in patients with advanced forms of prostate cancer when a reduced response to enzalutamide therapy is observed [69]
Systematic metabolic benefits In circulation, GLP-1 is primarily produced by intestinal L cells and pancreatic cells (its activity remains controversial), stimulated by the digestion of food or bile acids
By accelerating recovery, reducing downtime from injuries, and enhancing overall physical function, athletes can maintain peak performance and reduce the likelihood of recurrent injuries